Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ETOPOSIDE Cause Intentional product use issue? 398 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 398 reports of Intentional product use issue have been filed in association with ETOPOSIDE (Avopef). This represents 0.8% of all adverse event reports for ETOPOSIDE.

398
Reports of Intentional product use issue with ETOPOSIDE
0.8%
of all ETOPOSIDE reports
129
Deaths
106
Hospitalizations

How Dangerous Is Intentional product use issue From ETOPOSIDE?

Of the 398 reports, 129 (32.4%) resulted in death, 106 (26.6%) required hospitalization, and 26 (6.5%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ETOPOSIDE. However, 398 reports have been filed with the FAERS database.

What Other Side Effects Does ETOPOSIDE Cause?

Off label use (6,495) Febrile neutropenia (5,966) Disease progression (3,776) Drug ineffective (3,687) Neutropenia (3,641) Thrombocytopenia (3,085) Product use in unapproved indication (2,774) Anaemia (2,586) Pyrexia (2,453) Sepsis (2,211)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which ETOPOSIDE Alternatives Have Lower Intentional product use issue Risk?

ETOPOSIDE vs ETORICOXIB ETOPOSIDE vs ETRASIMOD ARGININE ETOPOSIDE vs ETRAVIRINE ETOPOSIDE vs EUCALYPTOL\MENTHOL\METHYL SALICYLATE\THYMOL ETOPOSIDE vs EVEROLIMUS

Related Pages

ETOPOSIDE Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue ETOPOSIDE Demographics